ISO-690 (author-date, English)

ROJAS RESTREPO, Jessica L., CABALLERO OTEYZA, Andrés, HÜBSCHER, Katrin, HABERSTROH, Hanna, FLIEGAUF, Manfred, KELLER, Bärbel, KOBBE, Robin, WARNATZ, Klaus, EHL, Stephan, PROIETTI, Michele und GRIMBACHER, Bodo, 2022. Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study. Freiburg: Universität.

Elsevier - Harvard (with titles)

Rojas Restrepo, J.L., Caballero Oteyza, A., Hübscher, K., Haberstroh, H., Fliegauf, M., Keller, B., Kobbe, R., Warnatz, K., Ehl, S., Proietti, M., Grimbacher, B., 2022. Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study. Universität, Freiburg. https://doi.org/10.3389/fimmu.2021.786516

American Psychological Association 7th edition

Rojas Restrepo, J. L., Caballero Oteyza, A., Hübscher, K., Haberstroh, H., Fliegauf, M., Keller, B., Kobbe, R., Warnatz, K., Ehl, S., Proietti, M., & Grimbacher, B. (ca. 2022). Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study [Cd]. Universität. https://doi.org/10.3389/fimmu.2021.786516

Springer - Basic (author-date)

Rojas Restrepo JL, Caballero Oteyza A, Hübscher K, Haberstroh H, Fliegauf M, Keller B, Kobbe R, Warnatz K, Ehl S, Proietti M, Grimbacher B (2022) Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study. Universität, Freiburg

Juristische Zitierweise (Stüber) (Deutsch)

Rojas Restrepo, Jessica L./ Caballero Oteyza, Andrés/ Hübscher, Katrin/ Haberstroh, Hanna/ Fliegauf, Manfred/ Keller, Bärbel/ Kobbe, Robin/ Warnatz, Klaus/ Ehl, Stephan/ Proietti, Michele/ Grimbacher, Bodo, Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study, Freiburg 2022.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.